Prevention of Seasonal Affective Disorder
NCT00046449 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2015-06-04
Summary
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Conditions
- Seasonal Affective Disorder (SAD)
Interventions
- DRUG
-
Investigational Seasonal Affective Disorder (SAD) Drug
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-09-30
- Primary Completion
- 2003-06-30
- Completion
- 2003-06-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
NCT04479852 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849693 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Depression and Associated Painful Physical Symptoms
NCT01070329 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
NCT01273376 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)
NCT00839176 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of GW679769 In Major Depressive Disorder
NCT00102492 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
NCT02476058 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
NCT01000805 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
NCT00036309 ·Status: COMPLETED ·Phase: PHASE3
-
Wellbutrin XL for Dysthymic Disorder
NCT00225251 ·Status: COMPLETED ·Phase: PHASE4
-
An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
NCT00057226 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine
NCT06280235 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
NCT06029426 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression
NCT00429260 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT01110902 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo
NCT04221230 ·Status: COMPLETED ·Phase: PHASE2
-
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
NCT00057213 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
NCT01153009 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
NCT00042562 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose Study of BMS-820836
NCT00964912 ·Status: COMPLETED ·Phase: PHASE1
-
Modafinil for Atypical Depression
NCT00215176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of Depression
NCT05849272 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder
NCT03000530 ·Status: COMPLETED ·Phase: PHASE2
-
An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression
NCT00319709 ·Status: COMPLETED ·Phase: PHASE3